[1]徐莉,黄晶.无症状性室性期前收缩预后和治疗进展[J].心血管病学进展,2015,(6):704-708.[doi:10.3969/j.issn.1004-3934.2015.06.012]
　XU Li,HUANG Jing.Advances in Prognosis and Management of Asymptomatic Premature Ventricular Complexes[J].Advances in Cardiovascular Diseases,2015,(6):704-708.[doi:10.3969/j.issn.1004-3934.2015.06.012]
点击复制

无症状性室性期前收缩预后和治疗进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2015年6期
页码:
704-708
栏目:
综述
出版日期:
2016-06-20

文章信息/Info

Title:
Advances in Prognosis and Management of Asymptomatic Premature Ventricular Complexes
作者:
徐莉; 黄晶
重庆医科大学附属第二医院心血管内科,重庆 400010
Author(s):
XU Li;  HUANG Jing
Department of Cardiology,The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
关键词:
室性期前收缩;  无症状;  预后;  治疗;  导管消融
Keywords:
premature ventricular complexes;  asymptomatic;  prognosis;  management;  catheter ablation
分类号:
R541.7
DOI:
10.3969/j.issn.1004-3934.2015.06.012
文献标志码:
A
摘要:
室性期前收缩是临床实践中常见的心律失常之一。大多数室性期前收缩患者没有临床症状。没有器质性心脏病的无症状性室性期前收缩患者预后相对较好,然而,频发的无症状性室性期前收缩可能与多种心血管事件和死亡风险增加有关,而且这类患者可能更倾向于发展成心动过速诱导的心肌病。因此,对无症状性室性期前收缩患者进行合理的临床评估至关重要。决定是否针对无症状性室性期前收缩进行治疗主要基于3个因素:基础心脏疾病、室性期前收缩的负荷、心功能状况。治疗室性期前收缩的方法主要包括药物治疗和导管消融治疗。导管消融治疗已经成为治疗室性期前
Abstract:
Premature ventricular complexes(PVCs)are a common occurrence in clinical practice. In many patients with ectopic ventricular events manifest as asymptomatic, isolated PVCs that have a relatively benign prognosis in those without structural heart disease. However, frequent asymptomatic PVCs may be associated with a substantial increase in the risk of mortality, cardiovascular events, new-onset heart failure, transient ischemic accident, sudden and total cardiac death. In the patients who have frequent PVCs, the asymptomatic subjects tend to have tachycardia-induced cardiomyopathy at initial presentation. Appropriate clinical evaluation and investigations are important in assessing patients with asymptomatic PVCs, so that effective treatment can be targeted. The decision to treat asymptomatic PVCs, either pharmacologically or via catheter ablation, should be predicated on three factors: the concomitant structural heart disease, the burden of the PVCs, and the status of ventricular function. Catheter ablation has emerged as a safe and effective option for the treatment of PVCs.

参考文献/References:

[1] Ng GA. Treating patients with ventricular ectopic beats[J]. Heart,2006,92(11):1707-1712.
[2] Huang SKS, Wood MA. Catheter Ablation of Cardiac Arrhythmias[M]. 2nd Edition. Philadelphia: Elsevier Saunders, 2011.
[3] Adams JC, Srivathsan K, Shen WK. Advances in management of premature ventricular contractions[J]. J Interv Card Electrophysiol,2012,35(2):137-149.
[4] Eugenio PL. Frequent premature ventricular contractions: an electrical link to cardiomyopathy[J]. Cardiol Rev,2015,23(4):168-172.
[5] Hachiya H, Aonuma K,Yamauchi Y,et al. How to diagnose, locate, and ablate coronary cusp ventricular tachycardia[J]. J Cardiovasc Electrophysiol,2002,13(6):551-556.
[6] Kennedy HL,Whitlock JA, Sprague MK, et al.Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy[J]. N Engl J Med,1985,312(4):193-197.
[7] Agarwal SK, Simpson RJ Jr, Rautaharju P, et al. Relation of ventricular premature complexes to heart failure(from the Atherosclerosis Risk In Communities [ARIC] Study)[J]. Am J Cardiol,2012,109(1):105-109.
[8] Ataklte F, Erqou S, Laukkanen J, et al. Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations[J]. Am J Cardiol,2013,112(8):1263-1270.
[9] Qureshi W, Shah AJ, Salahuddin T, et al. Long-term mortality risk in individuals with atrial or ventricular premature complexes(results from the Third National Health and Nutrition Examination Survey)[J]. Am J Cardiol,2014,114(1):59-64.
[10] Massing MW,Simpson RJ Jr, Rautaharju PM, et al. Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality(from the Atherosclerosis Risk In Communities cohort)[J]. Am J Cardiol,2006,98(12):1609-1612.
[11] Cantillon DJ. Evaluation and management of premature ventricular complexes[J]. Cleve Clin J Med,2013,80(6):377-387.
[12] Lee YH, Zhong L, Roger VL, et al. Frequency, origin, and outcome of ventricular premature complexes in patients with or without heart diseases[J]. Am J Cardiol,2014,114(9):1373-1378.
[13] Bigger JT Jr, Dresdale FJ,Heissenbuttel RH, et al. Ventricular arrhythmias in ischemic heart disease: mechanism, prevalence, significance, and management[J]. Prog Cardiovasc Dis,1977,19(4):255-300.
[14] Moss AJ, Davis HT, DeCamilla J, et al. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction[J]. Circulation,1979,60(5):998-1003.
[15] Bikkina M, Larson MG, Levy D. Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study[J]. Ann Intern Med,1992,117(12):990-996.
[16] Zang M, Zhang T, Mao J, et al. Beneficial effects of catheter ablation of frequent premature ventricular complexes on left ventricular function[J]. Heart,2014,100(10):787-793.
[17] Baman TS,Lange DC, Ilg KJ, et al. Relationship between burden of premature ventricular complexes and left ventricular function[J]. Heart Rhythm,2010,7(7):865-869.
[18] Penela D, van Huls Van Taxis C,Aguinaga L,et al. Neurohormonal,structural,and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study[J]. J Am Coll Cardiol,2013,62(13):1195-202.
[19] Lakkireddy D, di Biase L, Ryschon K, et al. Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders[J]. J Am Coll Cardiol, 2012,60(16):1531-1539.
[20] Yokokawa M, Kim HM, Good E, et al. Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy[J]. Heart Rhythm,2012,9(1):92-95.
[21] Lü F, Benditt DG, Yu J, et al. Effects of catheter ablation of “asymptomatic” frequent ventricular premature complexes in patients with reduced(<48%)left ventricular ejection fraction[J]. Am J Cardiol,2012,110(6):852-856.
[22] Hasdemir C, Ulucan C, Yavuzgil O, et al. Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias:the incidence,clinical and electrophysiologic characteristics,and the predictors[J]. J Cardiovasc Electrophysiol,2011,22(6):663-668.
[23] Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial[J]. N Engl J Med,1991,324(12):781-788.
[24] Wijnmaalen AP, Delgado V,Schalij MJ, et al. Beneficial effects of catheter ablation on left ventricular and right ventricular function in patients with frequent premature ventricular contractions and preserved ejection fraction[J]. Heart,2010,96(16):1275-1280.
[25] Ling Z, Liu Z, Su L, et al. Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract:prospective randomized study[J]. Circ Arrhythm Electrophysiol,2014,7(2):237-243.
[26] Zhong L, Lee YH, Huang XM, et al. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study[J]. Heart Rhythm,2014,11(2):187-193.

相似文献/References:

[1]王皎.室性期前收缩性心肌病诊疗进展[J].心血管病学进展,2020,(6):563.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.001]
　WANG Jiao.Diagnosis and Treatment of Premature Ventricular Contraction-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(6):563.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.001]
[2]黄勇淇 田龙海 杨龙.室性期前收缩心肌病[J].心血管病学进展,2022,(4):348.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.015]
　HUANG Yongqi,TIAN Longhai,YANG Long.Premature Ventricular Complexes Induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(6):348.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.015]
[3]时向民 李健 李世兴 张闯.调节束起源室性心律失常的研究进展[J].心血管病学进展,2022,(9):769.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.001]
　SHI Xiangmin,L I Jian,L I Shixing,et al.Ventricular Arrhythmia Originated from Moderator Band[J].Advances in Cardiovascular Diseases,2022,(6):769.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.001]

备注/Memo

备注/Memo:
基金项目:介入超声去肾交感化安全性探索(81370440) 作者简介:徐莉(1989—),住院医师,在读硕士,主要从事心律失常研究。Email: throughwinter0056@126.com 通信作者:黄晶(1962—),教授,博士生导师,硕士,主要从事新型超声诊疗仪器的研发、高强度聚焦超声在心血管病诊疗中的应用、冠心病介入治疗。Email: dr.hj@aliyun.com
更新日期/Last Update: 2016-06-20